CASE STUDY PRA’s Unique Model Leads to Client Satisfaction Project Team Uses Innovation and Flexibility to Overcome ChallengesPRA’s Unique Model Leads to Client Satisfaction Project Team Uses Innovation and Flexibility to Overcome Challenges Primary Endpoint Compare the efficacy and safety of Study Drug A and Study Drug B as monotherapy in newly diagnosed partial epilepsy PRA Services Full service Indication Epilepsy Drug Class Chemical entity Study Phase III Business Segment Product Registration Regions South Africa Western Europe Central Europe Eastern Europe Asia Pacific India STUDY DESCRIPTION A randomized, multi-center, double-blind study to compare the efficacy and safety of Study Drug A and Study Drug B as monotherapy in newly diagnosed partial epilepsy A la

Join for free to read